Loading stock data…
AirSculpt Technologies, Inc. (AIRS)
$2.79+0.26 (+10.04%)
Pre-Market$2.87+0.08 (+2.68%)· Last close Sep 4
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AirSculpt Technologies, Inc. in the Healthcare sector is trading at $2.79 with a market capitalization of $365M. Wall Street consensus targets $4.50 (2 analysts), implying a +61.0% move over the next 12 months. The stock is currently near its 52-week low of $1.51, remaining 15.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +61.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $39.39M↑ | $33.44M↓ | $34.99M↓ | $44.01M↑ | $39.37M |
| Gross Profit | $23.80M↑ | $19.77M↓ | $20.13M↓ | $26.81M↑ | $23.42M |
| Operating Income | -$1.80M↓ | -$1.52M↑ | -$2.61M↓ | $894,000↑ | -$1.59M |
| Net Income | -$2.40M↓ | $1.28M↑ | -$9.51M↓ | -$591,000↑ | -$2.85M |
Peer Comparison
JNJUNHPFE
Fundamentals
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$364.72M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.02
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-11.19%
Volume
Today's trading volume
1.59M
Recent News
Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
AirSculpt (AIRS) Q2 2026 Earnings Call Transcript
Same-center case growth turned positive for second consecutive quarter.
AirSculpt Technologies (AIRS) After Q2 Results Is The Valuation Gap Still Real
AirSculpt Technologies (AIRS) is back in focus after reporting Q2 2026 results that showed slightly lower sales and a wider net loss, while management reaffirmed full year revenue guidance at the lower end of its range. See our latest analysis for AirSculpt Technologies. The Q2 2026 earnings release and reaffirmed revenue outlook have landed after a period of sharp share price swings for AirSculpt Technologies, with the stock up strongly year to date but total shareholder return over the past...
AirSculpt Technologies Inc (AIRS) (Q2 2026) Earnings Call Highlights: Strategic Investments ...
Despite a 2.5% revenue dip, the company posts its second consecutive quarter of case growth and expands its procedure portfolio to capture the GLP-1 market.
Does AirSculpt (AIRS) Reaffirmed 2026 Revenue Guidance Offset Concerns From Softer Q2 Results?
AirSculpt Technologies reported past second-quarter 2026 results showing sales of US$42.9 million versus US$44.01 million a year earlier and a wider net loss of US$1.11 million, while six-month sales slipped to US$82.29 million with a modestly higher cumulative net loss of US$3.51 million. Despite the softer top line and continued losses, the company reaffirmed its full-year 2026 revenue outlook at the lower end of its US$151 million to US$157 million guidance range, signaling management’s...